These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11858221)

  • 1. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Barlam T; Moellering R
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11858221
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Petrof EO; Schwartz DN; Quinn JP
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11858220
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Sandel DC; Wang CT; Kessler S
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11844861
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.
    Wolk M; Valinsky L; Sompolinsky D; Sechter I; Schmidt H; Tetry S; Agmon V
    FEMS Microbiol Lett; 2004 Oct; 239(2):249-54. PubMed ID: 15476973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens.
    Karlowsky JA; Kasloff S; Nichol KA; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):283-7. PubMed ID: 17376632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004.
    Barisić Z; Borzić E; Kraljević KS; Carev M; Zoranić V; Kaliterna V
    Int J Antimicrob Agents; 2005 Jun; 25(6):550-1. PubMed ID: 15878822
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 10. Multi-drug resistance of Escherichia coli from the urinary tract.
    Rafay AM; Nsanze HN
    Saudi Med J; 2003 Mar; 24(3):261-4. PubMed ID: 12704500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotyping and transferability of drug resistance in clinical isolates of E. coli.
    Husain RA; Wadher BJ; Daginawala HF; Deshmukh SR; Nagoba BS
    Indian J Pathol Microbiol; 1995 Oct; 38(4):355-7. PubMed ID: 9726143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections.
    Manges AR; Perdreau-Remington F; Solberg O; Riley LW
    J Infect; 2006 Jul; 53(1):25-9. PubMed ID: 16269177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli O:K:H: serotypes in urinary tract infection.
    Adetosoye AI
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):463-9. PubMed ID: 7036587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enteropathogenic Escherichia coli serotypes in urinary tract infections].
    Galiński J; Nowicki B; Namysł E
    Med Dosw Mikrobiol; 1984; 36(4):215-21. PubMed ID: 6398849
    [No Abstract]   [Full Text] [Related]  

  • 16. Escherichia coli isolated from urinary tract infections in Hong Kong, 1969 to 1976.
    Wong WT; Bettelheim KA
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):279-83. PubMed ID: 7041486
    [No Abstract]   [Full Text] [Related]  

  • 17. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can phylogenetic type predict resistance development?
    Nazir H; Cao S; Hasan F; Hughes D
    J Antimicrob Chemother; 2011 Apr; 66(4):778-87. PubMed ID: 21393154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.